{
    "root": "889225d1-6257-4b32-b9cc-5f9c459c994a",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "SIMBRINZA",
    "value": "20250311",
    "ingredients": [
        {
            "name": "Brinzolamide",
            "code": "9451Z89515"
        },
        {
            "name": "Brimonidine Tartrate",
            "code": "4S9CL2DY2H"
        },
        {
            "name": "Benzalkonium Chloride",
            "code": "F5UM2KM3W7"
        },
        {
            "name": "Boric Acid",
            "code": "R57ZHV85D4"
        },
        {
            "name": "Carbomer Homopolymer Type B (allyl Pentaerythritol Crosslinked)",
            "code": "HHT01ZNK31"
        },
        {
            "name": "Mannitol",
            "code": "3OWL53L36A"
        },
        {
            "name": "Propylene Glycol",
            "code": "6DC9Q167V3"
        },
        {
            "name": "Water",
            "code": "059QF0KO0R"
        },
        {
            "name": "Sodium Chloride",
            "code": "451W47IQ8X"
        },
        {
            "name": "Tyloxapol",
            "code": "Y27PUL9H56"
        },
        {
            "name": "Hydrochloric Acid",
            "code": "QTT17582CB"
        },
        {
            "name": "Sodium Hydroxide",
            "code": "55X04QC32I"
        }
    ],
    "indications": "SIMBRINZA (brinzolamide/brimonidine tartrate ophthalmic suspension) 1%/0.2% is a fixed combination of a carbonic anhydrase inhibitor and an alpha 2 adrenergic receptor agonist indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.",
    "contraindications": "The recommended dose is one drop of SIMBRINZA in the affected eye(s) three times daily. Shake well before use. SIMBRINZA ophthalmic suspension may be used concomitantly with other topical ophthalmic drug products to lower IOP. If more than one topical ophthalmic drug is being used, the drugs should be administered at least five (5) minutes apart.",
    "warningsAndPrecautions": "SIMBRINZA (brinzolamide/brimonidine tartrate ophthalmic suspension) 1%/0.2% is supplied in white low density polyethylene (LDPE) DROP-TAINER® bottles with a natural LDPE dispensing-tip and light green polypropylene cap as follows:\n                  8 mL in a 10 mL bottle NDC 0065-4147-27  \n                  \n                     Storage and Handling\n                  \n                  Store SIMBRINZA at 2°C to 25°C (36°F to 77°F). After opening, SIMBRINZA can be used until the expiration date on the bottle.",
    "adverseReactions": "Hypersensitivity to any component of this product. (4.1) Neonates and infants (under the age of two years). (4.2)"
}